Blog: Fresh insights driving agile collaboration

29 de octubre de 2024 Strategies for externally controlled single-arm trials Leer más about Strategies for externally controlled single-arm trials

27 de octubre de 2024 The rising potential of liquid biopsies in oncology Leer más about The rising potential of liquid biopsies in oncology

22 de octubre de 2024 Key CMC strategies for the development of cell and gene therapies Leer más about Key CMC strategies for the development of cell and gene therapies

21 de octubre de 2024 Dialysis trials need to be patient-centric AND dialysis-centric Leer más about Dialysis trials need to be patient-centric AND dialysis-centric

20 de octubre de 2024 Future directions in liquid biopsy technology Leer más about Future directions in liquid biopsy technology

8 de octubre de 2024 Advanced therapies: The advantage of early and frequent regulatory interactions Leer más about Advanced therapies: The advantage of early and frequent regulatory interactions

30 de septiembre de 2024 Addressing challenges of data management for cosmetic, personal care and over-the-counter products Leer más about Addressing challenges of data management for cosmetic, personal care and over-the-counter products

23 de septiembre de 2024 Incorporating sustainability into our clinical research operations Leer más about Incorporating sustainability into our clinical research operations

16 de septiembre de 2024 Medicare drug price negotiations Leer más about Medicare drug price negotiations

9 de septiembre de 2024 NICE technology appraisals of oncology treatments Leer más about NICE technology appraisals of oncology treatments

20 de agosto de 2024 How Fortrea helped enroll over 5.000 patients 30 days early Leer más about How Fortrea helped enroll over 5.000 patients 30 days early

12 de agosto de 2024 Creating a combined advanced therapy medicinal product as an SME in the EU Leer más about Creating a combined advanced therapy medicinal product as an SME in the EU

7 de agosto de 2024 Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease Leer más about Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease

31 de julio de 2024 Understanding the three types of Advanced Therapy Medicinal Products (ATMPs) Leer más about Understanding the three types of Advanced Therapy Medicinal Products (ATMPs)

11 de julio de 2024 The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union Leer más about The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union

3 de julio de 2024 Clinical Development in the Precision Medicine Era Leer más about Clinical Development in the Precision Medicine Era

28 de junio de 2024 Diversity Action Plans: What sponsors need to know about the latest FDA guidance Leer más about Diversity Action Plans: What sponsors need to know about the latest FDA guidance

24 de junio de 2024 Enhancing endpoint protection in pain management clinical trials Leer más about Enhancing endpoint protection in pain management clinical trials

21 de junio de 2024 Importance of patient perspectives in neurology clinical trials Leer más about Importance of patient perspectives in neurology clinical trials

11 de junio de 2024 It's never too early for a thorough oncology product development strategy in the APAC region Leer más about It's never too early for a thorough oncology product development strategy in the APAC region

4 de junio de 2024 Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey Leer más about Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey

31 de mayo de 2024 Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars Leer más about Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars

31 de mayo de 2024 Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation Leer más about Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation

20 de mayo de 2024 Celebrating Clinical Trials Day: A look back to move forward Leer más about Celebrating Clinical Trials Day: A look back to move forward

15 de mayo de 2024 Patient-Centric Solutions for Cell and Gene Therapy Trials Leer más about Patient-Centric Solutions for Cell and Gene Therapy Trials

6 de mayo de 2024 Scientific Research Amidst the Russia-Ukraine Conflict Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict. Leer más about Scientific Research Amidst the Russia-Ukraine Conflict

25 de abril de 2024 Beauty and Personal Care Research Discover Fortrea's research on beauty and personal care, focusing on sustainable trends. Read our blog for insights into the future of beauty and personal care. Leer más about Beauty and Personal Care Research

15 de abril de 2024 Rare diseases: A spotlight on Gaucher disease research in India Explore Fortrea's focus on Gaucher disease research in India, addressing rare diseases with innovative treatment approaches. Leer más about Rare diseases: A spotlight on Gaucher disease research in India

25 de marzo de 2024 Focusing on Rare Kidney Diseases with Unique Collaborative Efforts Explore Fortrea's unique collaborative efforts in researching and addressing rare kidney diseases through advanced methodologies and patient-centric approaches. Leer más about Focusing on Rare Kidney Diseases with Unique Collaborative Efforts

14 de marzo de 2024 Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials Learn about Fortrea's agile strategies for hybrid outsourcing in clinical trials, enhancing flexibility and efficiency. Leer más about Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials

27 de febrero de 2024 Rare Disease Day: Celebrating Progress and Hope for the Future Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future. Leer más about Rare Disease Day: Celebrating Progress and Hope for the Future

23 de febrero de 2024 Rare Disease Clinical Trials Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions. Leer más about Rare Disease Clinical Trials

11 de febrero de 2024 Ensayos clínicos en enfermedades poco comunes Discover Fortrea's efforts in conducting clinical trials for rare diseases, aiming to develop effective treatments. Leer más about Clinical Trials in Rare Disease

25 de enero de 2024 Continuous Glucose Monitoring Explore key considerations for using continuous glucose monitoring in diabetes management. Read Fortrea's blog for insights into CGM technology and strategies. Leer más about Continuous Glucose Monitoring

21 de enero de 2024 Clinical Trials Regulation and CTIS Stay informed with Fortrea's blog on clinical trials regulation and regulatory updates. Prepare for upcoming changes and ensure compliance in clinical research. Leer más about Clinical Trials Regulation and CTIS

8 de enero de 2024 Innovative Advances in Ophthalmology Medical Device Development Discover Fortrea's innovative advances in ophthalmology medical device development, enhancing eye disease treatments. Leer más about Innovative Advances in Ophthalmology Medical Device Development

12 de diciembre de 2023 Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries Fortrea addresses the challenges and strategies in conducting clinical trials for type 2 diabetes, aiming to improve treatment outcomes. Leer más about Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries

4 de diciembre de 2023 Fortrea Shanghai Office Learn about Fortrea's Shanghai office and its sustainability initiatives. Explore our efforts towards promoting a greener and sustainable future. Leer más about Fortrea Shanghai Office

20 de noviembre de 2023 SGLT2 Inhibitors for Pediatric Patients Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection. Leer más about SGLT2 Inhibitors for Pediatric Patients

16 de noviembre de 2023 Promoting Access to Innovative Cardiac Medical Devices Fortrea's efforts in promoting access to innovative cardiac medical devices, aiming to improve cardiovascular health through cutting-edge technology. Leer más about Promoting Access to Innovative Cardiac Medical Devices

27 de octubre de 2023 Key takeaways from the 2023 SCDM AC & Leadership Forum Discover the key insights and takeaways from the 2023 SCDM AC Leadership Forum, highlighting advancements and discussions in clinical data management. Leer más about Key takeaways from the 2023 SCDM AC & Leadership Forum

1 de octubre de 2023 Standardizing cosmetovigilence Learn about Fortrea's efforts in standardizing cosmetovigilance to ensure the safety and efficacy of cosmetic products. Leer más about Standardizing cosmetovigilence

28 de septiembre de 2023 Advancing cell and gene therapy frontiers Discover Fortrea's advancements in cell and gene therapy. Read our blog for insights into the latest breakthroughs and innovative treatments in genetic medicine. Leer más about Advancing cell and gene therapy frontiers

21 de septiembre de 2023 Seguridad del paciente en ensayos clínicos Explore Fortrea's commitment to patient safety in clinical trials. Read our blog for insights and strategies to ensure patient protection and trial integrity. Leer más about Patient Safety in Clinical Trials

21 de septiembre de 2023 Uso de la medicina de precisión para hacer avances en los ensayos clínicos en América Latina Learn how Fortrea is advancing clinical trials in Latin America through precision medicine, enhancing treatment efficacy and patient outcomes. Leer más about Leveraging Precision Medicine to Advance Clinical Trials in Latin America

11 de septiembre de 2023 Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials Explore Fortrea's strategies for clinical trial rescue and transition, ensuring successful outcomes and continuity. Leer más about Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials